UNLABELLED: Although [1-11C]acetate has been validated as a PET tracer for myocardial oxygen consumption (MVO2) in animals and humans, mono- and biexponential fitting of the tissue time-activity curve yields only estimates of MVO2. This study attempts to develop and validate a simple tracer kinetic model in vivo for estimation of regional MVO2. METHODS: Twenty-seven experiments were performed in 12 anesthetized dogs with [1-11C]acetate and serial PET images under different MBF and MVO2 (baseline, ischemia, xylazine, dobutamine and dipyridamole). Estimates of MVO2 were obtained from dynamic [1-11C]acetate PET and model fitting. MBF was measured by radiolabeled microspheres, and MVO2 was calculated by the Fick method using arterial and coronary blood samples. RESULTS: The proposed model fitted equally well for all study conditions with a multiple correlation coefficient of 0.985 +/- 0.026. Estimated MVO2 correlated linearly with measured MVO2 (y = 0.033 + 0.690x, r = 0.92, s.e. of estimates = 0.020). CONCLUSION: This study indicates that MVO2 can be assessed with PET and [1-11C]acetate over a wide range with a simple tracer kinetic model.
UNLABELLED: Although [1-11C]acetate has been validated as a PET tracer for myocardial oxygen consumption (MVO2) in animals and humans, mono- and biexponential fitting of the tissue time-activity curve yields only estimates of MVO2. This study attempts to develop and validate a simple tracer kinetic model in vivo for estimation of regional MVO2. METHODS: Twenty-seven experiments were performed in 12 anesthetized dogs with [1-11C]acetate and serial PET images under different MBF and MVO2 (baseline, ischemia, xylazine, dobutamine and dipyridamole). Estimates of MVO2 were obtained from dynamic [1-11C]acetate PET and model fitting. MBF was measured by radiolabeled microspheres, and MVO2 was calculated by the Fick method using arterial and coronary blood samples. RESULTS: The proposed model fitted equally well for all study conditions with a multiple correlation coefficient of 0.985 +/- 0.026. Estimated MVO2 correlated linearly with measured MVO2 (y = 0.033 + 0.690x, r = 0.92, s.e. of estimates = 0.020). CONCLUSION: This study indicates that MVO2 can be assessed with PET and [1-11C]acetate over a wide range with a simple tracer kinetic model.
Authors: K F Kofoed; P R Hansen; S Holm; J D Hove; K Chen; W Jin; M Jensen; H Iida; B Hesse; J H Svendsen; H Kelbaek Journal: J Nucl Cardiol Date: 2000 May-Jun Impact factor: 5.952
Authors: L J Klein; F C Visser; S A Nurmohamed; A Vink; J H Peters; P Knaapen; P S Kruijer; J D Herscheid; G J Teule; C A Visser Journal: J Nucl Cardiol Date: 2000 May-Jun Impact factor: 5.952
Authors: Kyle S McCommis; Xiang He; Dana R Abendschein; Pradeep M Gupte; Robert J Gropler; Jie Zheng Journal: Magn Reson Med Date: 2010-06 Impact factor: 4.668
Authors: Selim Demirdelen; Philip Z Mannes; Ali Mubin Aral; Joseph Haddad; Steven A Leers; Delphine Gomez; Sina Tavakoli Journal: J Nucl Cardiol Date: 2021-01-08 Impact factor: 3.872
Authors: Weena J Y Chen; Michaela Diamant; Karin de Boer; Hendrik J Harms; Lourens F H J Robbers; Albert C van Rossum; Mark H H Kramer; Adriaan A Lammertsma; Paul Knaapen Journal: Cardiovasc Diabetol Date: 2017-05-19 Impact factor: 9.951